Champions Oncology (CSBR) Other financing activities (2011 - 2026)
Champions Oncology (CSBR) posted quarterly Other financing activities of $3000.0 for Q1 2026, down 92.11% year-over-year from $38000.0 in Q1 2025, and down 98.55% quarter-over-quarter from $207000.0 in Q4 2025.
Champions Oncology (CSBR) Other financing activities (2011 - 2026) Analysis & Trends
Champions Oncology's Other financing activities history runs 12 years deep, the most recent figure standing at $3000.0 for Q1 2026.
- In Q1 2026, Other financing activities fell 92.11% year-over-year to $3000.0; the TTM figure through Apr 2026 stood at $234000.0 (down 26.88% YoY), while the FY2026 annual figure was $234000.0, down 26.88% from the prior year.
- Other financing activities for Q1 2026 stood at $3000.0, down from $207000.0 in the prior quarter.
- The five-year high for Other financing activities was $276000.0 in Q4 2024, with the low at -$1000.0 in Q2 2023.
- The 4-year median for Other financing activities is $18000.0 (2023), against an average of $80600.0.
- The sharpest annual moves came in 2025 and 2026: Other financing activities surged 500.0% in 2025, then slumped 92.11% in 2026.
- Champions Oncology's Other financing activities stood at $240000.0 in 2023, then grew by 15.0% to $276000.0 in 2024, then retreated by 25.0% to $207000.0 in 2025, then plunged by 98.55% to $3000.0 in 2026.
- Business Quant data shows CSBR's Other financing activities at $3000.0 in Q1 2026, $207000.0 in Q4 2025, and $24000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | Champions Oncology | 69.30 Mn | 69.30 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 3,000.00 |
| Jan 31, 2026 | 3,000.00 |
| Oct 31, 2025 | 207,000.00 |
| Oct 31, 2025 | 207,000.00 |
| Jul 31, 2025 | 24,000.00 |
| Jul 31, 2025 | 24,000.00 |
| Apr 30, 2025 | 6,000.00 |
| Apr 30, 2025 | 6,000.00 |
| Jan 31, 2025 | 38,000.00 |
| Jan 31, 2025 | 38,000.00 |
| Oct 31, 2024 | 276,000.00 |
| Oct 31, 2024 | 276,000.00 |
| Apr 30, 2024 | 1,000.00 |
| Apr 30, 2024 | 1,000.00 |
| Oct 31, 2023 | 240,000.00 |
| Oct 31, 2023 | 240,000.00 |
| Jul 31, 2023 | 12,000.00 |
| Jul 31, 2023 | 12,000.00 |
| Apr 30, 2023 | -1,000.00 |
| Apr 30, 2023 | -1,000.00 |